# Commission Implementing Regulation (EU) No 489/2013Show full title

Commission Implementing Regulation (EU) No 489/2013 of 27 May 2013 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically            active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the            substance double stranded ribonucleic acid homologous to viral ribonucleic acid coding for part of the coat protein and part            of the intergenic region of the Israel Acute Paralysis Virus (Text with EEA relevance)         

        - Previous
        - Next

U.K.

# Commission Implementing Regulation (EU) No 489/2013                     

# of 27 May 2013

# amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding                        maximum residue limits in foodstuffs of animal origin, as regards the substance double stranded ribonucleic acid homologous                        to viral ribonucleic acid coding for part of the coat protein and part of the intergenic region of the Israel Acute Paralysis                        Virus                     

# (Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community                           procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin,                           repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council                           and Regulation (EC) No 726/2004 of the European Parliament and of the Council(1), and in particular Article 14 in conjunction with Article 17 thereof,                        

Having regard to the opinion of the European Medicines Agency formulated by the Committee for Medicinal Products for Veterinary                           Use,                        

Whereas:

(1)The maximum residue limit (‘MRL’) for pharmacologically active substances intended for use in the Union in veterinary medicinal                              products for food-producing animals or in biocidal products used in animal husbandry should be established in accordance with                              Regulation (EC) No 470/2009.

(2)Pharmacologically active substances and their classification regarding MRLs in foodstuffs of animal origin are set out in                              the Annex to Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification                              regarding maximum residue limits in foodstuffs of animal origin(2).

(3)An application for the establishment of MRLs for double stranded ribonucleic acid homologous to viral ribonucleic acid coding                              for part of the coat protein and part of the intergenic region of the Israel Acute Paralysis Virus for bees has been submitted                              to the European Medicines Agency.

(4)The Committee for Medicinal Products for Veterinary Use has recommended that for this pharmacologically active substance a                              standard pharmacological and toxicological approach, including the setting of a level of acceptable daily intake, is not appropriate                              and that there is no need to establish an MRL, applicable to honey, for double stranded ribonucleic acid homologous to viral                              ribonucleic acid coding for part of the coat protein and part of the intergenic region of the Israel Acute Paralysis Virus                              for bees.

(5)According to Article 5 of Regulation (EC) No 470/2009 the European Medicines Agency is to always consider the use of MRLs                              established for a pharmacologically active substance in a particular foodstuff for another foodstuff derived from the same                              species, or MRLs established for a pharmacologically active substance in one or more species for other species. The Committee                              for Medicinal Products for Veterinary Use has concluded that the extrapolation to other food producing species cannot be supported                              for this substance.

(6)Table 1 of the Annex to Regulation (EU) No 37/2010 should therefore be amended to include the substance double stranded ribonucleic                              acid homologous to viral ribonucleic acid coding for part of the coat protein and part of the intergenic region of the Israel                              Acute Paralysis Virus for bees while establishing the absence of the need to establish a MRL, applicable to honey.

(7)The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal                              Products,

HAS ADOPTED THIS REGULATION:

# Article 1U.K.

The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.

# Article 2U.K.

This Regulation shall enter into force on the twentieth day following that of its publication in the *Official Journal of the European Union*.                  

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 27 May 2013.

*For the Commission*                            

*The President*                            

José Manuel Barroso                            

## ANNEXU.K.

In Table 1 of the Annex to Regulation (EU) No 37/2010, the following substance is inserted in alphabetical order:

1

OJ L 152, 16.6.2009, p. 11.                           

2

OJ L 15, 20.1.2010, p. 1.